Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03220308
Other study ID # 20016 MIND
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 18, 2016
Est. completion date February 22, 2019

Study information

Verified date March 2019
Source Karakter Kinder- en Jeugdpsychiatrie
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effectiveness of an 8-week mindfulness group training for children (8-16 years old) with ADHD in combination with a parallel mindful parenting training for their parents. Half of the participants will be randomly assigned to the mindfulness training in addition to care-as-usual (CAU); the other half to CAU-only.

The hypothesis is that compared to care-as-usual only, the addition of the mindfulness training will improve self-control of youth with ADHD.


Recruitment information / eligibility

Status Completed
Enrollment 103
Est. completion date February 22, 2019
Est. primary completion date July 26, 2018
Accepts healthy volunteers No
Gender All
Age group 8 Years to 16 Years
Eligibility Inclusion Criteria:

- Child has a clinical diagnosis of ADHD according to the Diagnostic and Statistical Manual of Mental Disorders; DSM-IV or DSM-5 system, and confirmed by a structured interview (The Schedule for Affective Disorders and Schizophrenia for school-Age Children (K-SADS)).

- Child receives CAU and has remaining ADHD-symptoms (average score > 1.0 on the investigator-rated DSM-5 items from the Conners' ADHD rating scale).

- Child is between 8 and 16 years old.

- At least one parent is willing to participate.

- ADHD medication dose is stable, or there is an informed decision on not taking ADHD medication.

- Psychiatric comorbidities are allowed except psychosis, bipolar illness, active suicidality, untreated posttraumatic stress disorder or substance use, provided ADHD is the primary diagnosis in the child; similarly, psychopathology in the parents is allowed except psychosis, bipolar disorder, active suicidality, untreated posttraumatic stress disorder or substance use.

- Child and parent have an estimated intelligence quotient (IQ) = 80.

- Child and parent have adequate mastery of Dutch language.

Exclusion Criteria:

- Child or the participating parent(s) have participated in a mindfulness programme in the past year or ever in a Mindful Parenting training.

- Child or parent is participating in another intervention study.

Study Design


Related Conditions & MeSH terms

  • Attention Deficit Disorder with Hyperactivity
  • Attention Deficit Hyperactivity Disorder
  • Hyperkinesis

Intervention

Other:
MYmind mindfulness training
The MYmind mindfulness training uses a standardised protocol based on mindfulness-based cognitive therapy. It consists of 8 weekly group sessions of 90 minutes for youth with ADHD, and parallel mindful parenting training for the parents. Eight weeks after the last session there is a single 90 minutes booster session.
Care-as-usual for children (8-16 years old) with ADHD
According to the Dutch Multidisciplinary guidelines for the diagnosis and treatment of ADHD, care-as-usual for children aged 8-16 years with ADHD consists of psycho-education and the prescription of medication approved for ADHD and/or evidence-based parent and/or teacher-administered behaviour therapy, preferably both medication and behaviour therapy. First-line option for medication is a psychostimulant, second-line option is atomoxetine, and third-line options are alpha-2 presynaptic agonists or tricyclic antidepressants (imipramine).

Locations

Country Name City State
Netherlands Karakter, Expertisecentrum voor kinder- en jeugdpsychiatrie Arnhem Gelderland
Netherlands Karakter, Expertisecentrum voor kinder- en jeugdpsychiatrie Ede Gelderland
Netherlands Karakter, Expertisecentrum voor kinder- en jeugdpsychiatrie Nijmegen Gelderland

Sponsors (6)

Lead Sponsor Collaborator
Karakter Kinder- en Jeugdpsychiatrie European Commission, Fonds Psychische Gezondheid, Radboud University, University of Amsterdam, UvA minds

Country where clinical trial is conducted

Netherlands, 

References & Publications (1)

Siebelink NM, Bögels SM, Boerboom LM, de Waal N, Buitelaar JK, Speckens AE, Greven CU. Mindfulness for children with ADHD and Mindful Parenting (MindChamp): Protocol of a randomised controlled trial comparing a family Mindfulness-Based Intervention as an add-on to care-as-usual with care-as-usual only. BMC Psychiatry. 2018 Jul 25;18(1):237. doi: 10.1186/s12888-018-1811-y. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline in parent-rated self-control of the child Behaviour Rating Inventory of Executive Function, parent-report (BRIEF-P) Baseline, 3, 5 and 9 months
Secondary Change from Baseline in parent-rated behaviour problems of the child Conners' Parent Rating Scales-Revised: Long (CPRS-R), subscales: inattentive and hyperactive-impulsive symptoms according to the 4th version of the Diagnostic and Statistical Manual (DSM-IV), oppositional, anxious/shy, social problems and the Emotional Lability index Baseline, 3, 5 and 9 months
Secondary Change from Baseline in parent-rated autistic social impairment of the child Social Responsiveness Scale, parent-report (SRS-P) Baseline, 3 and 9 months
Secondary Change from Baseline in parent-rated quality of life of the child KIDSCREEN-10, parent-report Baseline, 3 and 9 months
Secondary Change from Baseline in teacher-rated self-control of the child Behaviour Rating Inventory of Executive Function, teacher-report (BRIEF-T) Baseline, 3 and 5 months
Secondary Change from Baseline in teacher-rated behaviour problems of the child Conners' Teacher Rating Scales-Revised: Long (CTRS-R), subscales: inattentive and hyperactive-impulsive symptoms according to the 4th version of the Diagnostic and Statistical Manual (DSM-IV), oppositional, anxious/shy, social problems and the Emotional Lability index Baseline, 3 and 5 months
Secondary Change from Baseline in teacher-rated autistic social impairment of the child Social Responsiveness Scale, teacher-report (SRS-T) Baseline and 3 months
Secondary Change from Baseline in self-rated dispositional mindfulness of the child Child and Adolescent Mindfulness Measure (CAMM), self-report Baseline, 3, 5 and 9 months
Secondary Change from Baseline in self-rated brooding of the child Ruminative Response Scale (RRS), subscale: brooding, self-report Baseline, 3 and 9 months
Secondary Change from Baseline on the Stop task in the child Computer based neurocognitive assessments of self-control in the child Baseline, 3 and 9 months
Secondary Change from Baseline on the Probabilistic reversal learning task in the child Computer based neurocognitive assessments of self-control in the child Baseline, 3 and 9 months
Secondary Change from Baseline on the Temporal discounting task in the child Computer based neurocognitive assessments of self-control in the child Baseline, 3 and 9 months
Secondary Change from Baseline in self-rated self-control of the parent Behaviour Rating Inventory of Executive Function, self-report (BRIEF-A) Baseline, 3, 5 and 9 months
Secondary Change from Baseline in self-rated ADHD traits of the parent DSM-5 based ADHD traits, self-report Baseline, 3, 5 and 9 months
Secondary Change from Baseline in self-rated mindfulness in parenting of the parent Interpersonal Mindfulness in Parenting Scale (IM-P), self-report Baseline, 3, 5 and 9 months
Secondary Change from Baseline in self-rated autistic traits of the parent Short Autism Quotient Questionnaire-Adult Version (AQ-10), self-report Baseline, 3 and 9 months
Secondary Change from Baseline in self-rated symptoms of depression, anxiety and stress in the parent Depression Anxiety Stress Scale-21 (DASS-21), self-report Baseline, 3 and 9 months
Secondary Change from Baseline in self-rated emotional well-being, psychological well-being and social well-being of the parent Mental Health Continuum-Short Form (MHC-SF), self-report Baseline, 3 and 9 months
Secondary Change from Baseline in self-rated quality of life of the parent World Health Organization-Five Well-Being Index (WHO-5), self-report Baseline, 3 and 9 months
Secondary Change from Baseline in self-rated brooding of the parent Ruminative Response Scale (RRS), subscale: brooding, self-report Baseline, 3 and 9 months
Secondary Change from Baseline on the Stop task in the parent Computer based neurocognitive assessments of self-control in the parent Baseline, 3 and 9 months
Secondary Change from Baseline on the Probabilistic reversal learning task in the parent Computer based neurocognitive assessments of self-control in the parent Baseline, 3 and 9 months
Secondary Change from Baseline on the Temporal discounting task in the parent Computer based neurocognitive assessments of self-control in the parent Baseline, 3 and 9 months
See also
  Status Clinical Trial Phase
Recruiting NCT06129396 - Effects of Aerobic Exercise Intervention in Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) N/A
Completed NCT04779333 - Lifestyle Enhancement for ADHD Program 2 N/A
Recruiting NCT05935722 - Evaluation of a Home-based Parenting Support Program: Parenting Young Children N/A
Completed NCT03148782 - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase N/A
Completed NCT04832737 - Strength-based Treatment Approach for Adults With ADHD N/A
Recruiting NCT04631042 - Developing Brain, Impulsivity and Compulsivity
Recruiting NCT05048043 - Development of a Game-supported Intervention N/A
Completed NCT03337646 - Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism Phase 4
Not yet recruiting NCT06080373 - Formulation-based CBT for Adult Inmates With ADHD: A Randomized Controlled Trial N/A
Not yet recruiting NCT06454604 - Virtual Reality Treatment for Emerging Adults With ADHD Phase 2
Not yet recruiting NCT06406309 - Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD N/A
Completed NCT02911194 - a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT02477280 - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance Phase 4
Completed NCT02473185 - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest Phase 4
Completed NCT02555150 - A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD Phase 3
Completed NCT02390791 - New Technologies to Help Manage ADHD N/A
Completed NCT02780102 - Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD N/A
Completed NCT02829970 - Helping College Students With ADHD Lead Healthier Lifestyles N/A
Recruiting NCT04175028 - Neuromodulation of Executive Function in the ADHD Brain N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A